Edit Symbol List
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Spectrum Pharmaceuticals, Inc.Common Stock Intraday Chart
|Intraday||Last 52 Weeks|
|High||$ 7.25||$ 7.74|
|Low||$ 7.03||$ 4.14|
The current last sale of $7.09 is 71.26% Higher thanthe 52 week low.
Company Description (as filed with the SEC)
Our primary strategy is comprised of acquiring, developing, and commercializing a broad and diverse pipeline of late-stage clinical and commercial products. In addition to an efficient in-house clinical development organization with regulatory and data management capabilities, we have established a commercial infrastructure for our marketed products. Currently, we have six approved oncology/hematology products that target different types of non-Hodgkin's lymphoma ("NHL"), advanced metastatic colorectal cancer, acute lymphoblastic leukemia ("ALL"), and multiple myeloma ("MM"). We also have two drugs in late stage development: *SPI-2012, is being developed for chemotherapy-induced neutropenia in patients with breast cancer. ... More ...
Where does SPPI fit in the risk graph?
Nasdaq Official Price
|Annual EPS Est:||$-0.78|
|Quarterly EPS Est:||-0.34|